Article Versions Notes

Mauzo SH, Tetzlaff MT, Milton DR, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, et al. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers. 2019; 11(6):754. https://doi.org/10.3390/cancers11060754

Mauzo, Shakuntala H., Michael T. Tetzlaff, Denái R. Milton, Alan E. Siroy, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Doina Ivan, Jonathan L. Curry, Courtney W. Hudgens, Jennifer A. Wargo, and et al. 2019. "Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy" Cancers 11, no. 6: 754. https://doi.org/10.3390/cancers11060754

Mauzo, S. H., Tetzlaff, M. T., Milton, D. R., Siroy, A. E., Nagarajan, P., Torres-Cabala, C. A., Ivan, D., Curry, J. L., Hudgens, C. W., Wargo, J. A., Sahin, A. A., Pettaway, C. A., Prieto, V. G., & Aung, P. P. (2019). Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers, 11(6), 754. https://doi.org/10.3390/cancers11060754